Rani Therapeutics Holdings Inc. Gains 57.43%
Mon, Oct 14, 2024 at 07:08 PM
Rani Therapeutics Holdings Inc. (RANI:NASDAQ) rocketted at $3.18, a gain of 57.4%. On Mon, Oct 14, 2024, RANI:NASDAQ hit a New 2-Week High of $3.18. The stock appeared on our News Catalysts scanner on Sun, Oct 13, 2024 at 06:21 AM in the 'MISCELLANEOUS' category. From Mon, Sep 30, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
About Rani Therapeutics Holdings Inc. (RANI:NASDAQ)
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Tevogen Bio Holdings Inc Com (TVGN:NASDAQ), 187.14%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 132.71%
- Verb Technology Company, Inc. (VERB:NASDAQ), 58.41%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 57.43%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 51.65%
- Expion360 Inc. (XPON:NASDAQ), 47.28%
- Vision Marine Technologies Inc. (VMAR:NASDAQ), 44.1%
- Inventiva S.A. (IVA:NASDAQ), 41.27%
- Big Tree Cloud Holdings Limited (DSY:NASDAQ), 38.9%